United States· US:0023-4290_03500b7d-f60e-44a0-b57e-5030a35c82aa
LASTACAFT
A alcaftadine product containing alcaftadine, registered in United States by Allergan, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ALCAFTADINE
- Manufacturer
- Allergan, Inc.
- Country
- United States (US)
- ATC code
- S01GX11
- ATC class
- Alcaftadine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1100234290011 BOTTLE, PLASTIC in 1 CARTON (0023-4290-01) / 1 mL in 1 BOTTLE, PLASTIC
- ndc110023-4290-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01GX11
Alcaftadine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2a8da6c-590e-4fef-ad15-27677b73e56c GET /v1/drugs/b2a8da6c-590e-4fef-ad15-27677b73e56c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "2.5",
"substance": "ALCAFTADINE",
"productndc": "0023-4290",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA022134",
"marketing_category": "NDA"
}See everything about alcaftadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.